Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

473 Effect of nivolumab with or without relatlimab after stereotactic body radiotherapy in patients with advanced esophagogastric cancer

  • Chen Hu1
  • Valsamo Anagnostou2
  • Gavin Pereira3
  • Julie S Deutsch4
  • Rachel J Keogh5
  • Ali H Zaidi6
  • Kellie N Smith7
  • Kristen A Marrone5
  • Josephine L Feliciano5
  • Samira Hosseini-Nami5
  • K Ranh Voong5
  • Russell K Hales5
2 more authors
  • Ronan J Kelly8
  • Vincent K Lam5
8 affiliations
  1. 1Chongqing Key Laboratory of Precision Medicine and Prevention of Major Respiratory Diseases, Chongqing, China
  2. 26 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
  3. 3Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia
  4. 4Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  5. 5Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
  6. 6Allegheny Health Network, Pittsburgh, PA, USA
  7. 7Johns Hopkins School of Medicine, Baltimore, MD, USA
  8. 8Baylor University Medical Center, Dallas, TX, USA
Open at sourceDOICite

Related

  1. Retrospective intrafraction motion verification using triggered kilovoltage images during bone metastases stereotactic body radiotherapy
    Quentin Techer, Noé Grandgirard, Saturnin Sandjong +2
    Physics and Imaging in Radiation OncologyPeer-reviewedCC BY 4.0Full textSystems & synthetic biologyMedical imaging & radiologyHAL
  2. Comparison of 2 stereotactic radiotherapy regimens for brain metastases: Is higher always better?
    Vincent Bourbonne, Moncef Morjani, Brieg Dissaux +7
    Neuro-Oncology AdvancesPeer-reviewedCC BY-NC 4.0Full textGeneral biologyHAL
  3. Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Emeline Guiard, Florian Clatot, Caroline Even +5
    European Journal of CancerPeer-reviewedPublisher termsFull text20 citedGeneral biologyOncologyHAL
  4. Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
    S. Dalle, P. Saiag, C. Lebbé +13
    European journal of cancer skin cancerPeer-reviewedCC BY-NC-ND 4.0Full text1 citedImmunologyEpidemiology & public healthHAL
  5. Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
    Emilien Billon, Cécile Dalban, Stephane Oudard +17
    European Urology OncologyPeer-reviewedLicence not stated6 citedGeneral biologyHAL

Cite

BibTeXRIS
BibTeX
@article{hu2026effect,
  title = {{473 Effect of nivolumab with or without relatlimab after stereotactic body radiotherapy in patients with advanced esophagogastric cancer}},
  author = {Chen Hu and Valsamo Anagnostou and Gavin Pereira and Julie S Deutsch and Rachel J Keogh and Ali H Zaidi and Kellie N Smith and Kristen A Marrone and Josephine L Feliciano and Samira Hosseini-Nami and K Ranh Voong and Russell K Hales and Ronan J Kelly and Vincent K Lam},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0473},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0473},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 473 Effect of nivolumab with or without relatlimab after stereotactic body radiotherapy in patients with advanced esophagogastric cancer
AU  - Chen Hu
AU  - Valsamo Anagnostou
AU  - Gavin Pereira
AU  - Julie S Deutsch
AU  - Rachel J Keogh
AU  - Ali H Zaidi
AU  - Kellie N Smith
AU  - Kristen A Marrone
AU  - Josephine L Feliciano
AU  - Samira Hosseini-Nami
AU  - K Ranh Voong
AU  - Russell K Hales
AU  - Ronan J Kelly
AU  - Vincent K Lam
PY  - 2026
DA  - 2026/11/05
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0473
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0473
SN  - 2051-1426
ER  -